These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3041924)

  • 1. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Clin Rheumatol; 1990 Sep; 9(3):356-61. PubMed ID: 2261735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.
    Hauzeur JP; Appelboom T
    Rheumatol Int; 1989; 9(2):71-6. PubMed ID: 2682980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OM-8980 and D-penicillamine in the treatment of rheumatoid arthritis. A 12-month double-blind randomized study.
    Verstraeten A; Sileghem A; Dequeker J
    Scand J Rheumatol; 1990; 19(6):422-31. PubMed ID: 2259898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study.
    Brackertz D; Vischer TL
    J Rheumatol; 1989 Jan; 16(1):19-23. PubMed ID: 2654391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.
    Johnsen V; Borg G; Trang LE; Berg E; Brodin U
    Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
    Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
    J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
    Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
    [No Abstract]   [Full Text] [Related]  

  • 13. A 6-month randomized dose range study of OM-8980 in rheumatoid arthritis.
    Müller-Fassbender HR
    Br J Rheumatol; 1993 Aug; 32(8):746-50. PubMed ID: 8348280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pyritinol and auranofin in the treatment of rheumatoid arthritis. The European Multicentre Study Group.
    Lemmel EM
    Br J Rheumatol; 1993 May; 32(5):375-82. PubMed ID: 8495257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter double-blind comparison of auranofin and Tauredon].
    Kaik B; Bröll H
    Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
    Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
    Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of auranofin in patients with active early rheumatoid arthritis.
    Itokazu M; Matsunaga T; Oshita Y
    Clin Ther; 1995; 17(1):60-73. PubMed ID: 7758062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm treatment of rheumatoid arthritis with OM-8980. A retrospective study.
    Rosenthal M; Bahous I; Ambrosini G
    J Rheumatol; 1991 Dec; 18(12):1790-3. PubMed ID: 1795313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.